These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16967067)

  • 21. Icodextrin:a major problem for glucose dehydrogenase-based glucose point of care testing systems.
    Floré K; Delanghe J
    Acta Clin Belg; 2006; 61(6):351-4. PubMed ID: 17323845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significant hypoglycemia secondary to icodextrin peritoneal dialysate in a diabetic patient.
    Kroll HR; Maher TR
    Anesth Analg; 2007 Jun; 104(6):1473-4, table of contents. PubMed ID: 17513644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of icodextrin on glycemic and lipid profiles in diabetic patients undergoing peritoneal dialysis.
    Babazono T; Nakamoto H; Kasai K; Kuriyama S; Sugimoto T; Nakayama M; Hamada C; Furuya R; Hasegawa H; Kasahara M; Moriishi M; Tomo T; Miyazaki M; Sato M; Yorioka N; Kawaguchi Y;
    Am J Nephrol; 2007; 27(4):409-15. PubMed ID: 17622748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood glucose overestimation in diabetic patients on continuous ambulatory peritoneal dialysis for end-stage renal disease.
    Oyibo SO; Pritchard GM; McLay L; James E; Laing I; Gokal R; Boulton AJ
    Diabet Med; 2002 Aug; 19(8):693-6. PubMed ID: 12147153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Icodextrin allergy in a peritoneal dialysis patient.
    Fletcher S; Stables GA; Turney JH
    Nephrol Dial Transplant; 1998 Oct; 13(10):2656-8. PubMed ID: 9794582
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis].
    Opatrná S; Racek J; Stehlík P; Senft V; Sefrna F; Topolcan O; Opatrný K
    Cas Lek Cesk; 2002 May; 141(9):281-5. PubMed ID: 12061197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new form of acute adverse reaction to icodextrin in a peritoneal dialysis patient.
    Del Rosso G; Di Liberato L; Perilli A; Cappelli P; Bonomini M
    Nephrol Dial Transplant; 2000 Jun; 15(6):927-8. PubMed ID: 10831669
    [No Abstract]   [Full Text] [Related]  

  • 28. Interference of maltose, icodextrin, galactose, or xylose with some blood glucose monitoring systems.
    Schleis TG
    Pharmacotherapy; 2007 Sep; 27(9):1313-21. PubMed ID: 17723085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dextran antibodies in peritoneal dialysis patients treated with icodextrin.
    Aanen MC; de Waart DR; Williams PF; Out TA; Zweers MM; Krediet RT
    Perit Dial Int; 2002; 22(4):513-5. PubMed ID: 12322824
    [No Abstract]   [Full Text] [Related]  

  • 30. Icodextrin-associated peritonitis among CAPD patients.
    Seow YY; Iles-Smith H; Hirst H; Gokal R
    Nephrol Dial Transplant; 2003 Sep; 18(9):1951-2. PubMed ID: 12937264
    [No Abstract]   [Full Text] [Related]  

  • 31. Icodextrin-induced peritonitis: study of five cases and comparison with bacterial peritonitis.
    Touré F; Lavaud S; Mohajer M; Lavaud F; Canivet E; Nguyen P; Chanard J; Rieu P
    Kidney Int; 2004 Feb; 65(2):654-60. PubMed ID: 14717938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions.
    Parikova A; Zweers MM; Struijk DG; Krediet RT
    Adv Perit Dial; 2003; 19():186-90. PubMed ID: 14763059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sterile chemical peritonitis secondary to icodextrin: immunohistopathological description.
    Goffin E; Tintillier M; Cosyns JP; Devuyst O
    Perit Dial Int; 2002; 22(6):723-6. PubMed ID: 12556077
    [No Abstract]   [Full Text] [Related]  

  • 34. Icodextrin hypersensitivity in a CAPD patient.
    Lam-Po-Tang MK; Bending MR; Kwan JT
    Perit Dial Int; 1997; 17(1):82-4. PubMed ID: 9068028
    [No Abstract]   [Full Text] [Related]  

  • 35. Severe cutaneous hypersensitivity requiring permanent icodextrin withdrawal in a CAPD patient.
    Queffeulou G; Bernard M; Vrtovsnik F; Skhiri H; Lebrun-Vigne B; Hufnagel G; Michel C; Mignon F
    Clin Nephrol; 1999 Mar; 51(3):184-6. PubMed ID: 10099892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erroneously elevated glucose values due to maltose interference in mutant glucose dehydrogenase pyrroloquinolinequinone (mutant GDH-PQQ) based glucometer.
    Chakraborty PP; Patra S; Bhattacharjee R; Chowdhury S
    BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28500115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of glucose dehydrogenase (GDH) based and glucose oxidase (GOX) based blood glucose meter systems at moderately high altitude.
    Bilen H; Kilicaslan A; Akcay G; Albayrak F
    J Med Eng Technol; 2007; 31(2):152-6. PubMed ID: 17365439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. False elevations in blood glucose readings with use of icodextrin (extraneal) peritoneal dialysis solution.
    Ng J; Elligsen M
    CANNT J; 2009; 19(4):37-8. PubMed ID: 20136034
    [No Abstract]   [Full Text] [Related]  

  • 39. Hyperinsulinism reduction associated with icodextrin treatment in continuous ambulatory peritoneal dialysis patients.
    Amici G; Orrasch M; Da Rin G; Bocci C
    Adv Perit Dial; 2001; 17():80-3. PubMed ID: 11510303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Icodextrin-induced sterile peritonitis: the Israeli experience.
    Rozenberg R; Magen E; Weissgarten J; Korzets Z
    Perit Dial Int; 2006; 26(3):402-5. PubMed ID: 16722035
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.